REGENERON PHARMACEUTICALS, INC. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
REGENERON PHARMACEUTICALS, INC. (REGN) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $482.31 million as of 2013-03-31, per its 10-Q filed 2013-05-03.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2013-11-05
- 2013-03-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $482.31M.
- 2012-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $354.96M.
- 2011-12-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $325.16M.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $482.31M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $354.96M 10-Q · filed 2013-11-05 |
| 2011-12-31 | $325.16M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |